Rxwire
Directory

Companies & regulators

Who the pharma news is about, ranked by stories in the last 30 days.

FDA

The US Food and Drug Administration.

45 stories · 30d39 live
XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
Eli Lilly

Maker of Mounjaro and Zepbound, diabetes and obesity leader.

19 stories · 30d19 live
U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes
Roche

Swiss pharma and diagnostics; Genentech in the US.

13 stories · 30d9 live
Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers
Merck & Co. (MSD)

Maker of Keytruda; MSD outside North America.

9 stories · 30d8 live
Merck Welireg, Eisai Lenvima combo approved for kidney cancer
Novo Nordisk

Danish maker of Ozempic and Wegovy.

5 stories · 30d3 live
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
AbbVie

Maker of Skyrizi, Rinvoq and Humira.

4 stories · 30d3 live
UChicago Medicine finaliza la fase de construcción del Pabellón Oncológico de la Fundación AbbVie, acercando a la realidad una nueva era en la atención del cáncer
Boehringer Ingelheim

Family-owned German drugmaker.

4 stories · 30d1 live
Boehringer Ingelheim offloads Shanghai CDMO to local antibody developer
Pfizer

US pharma giant: vaccines, oncology and internal medicine.

4 stories · 30d1 live
Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans
Johnson & Johnson

Innovative medicine (ex-Janssen) and medtech.

3 stories · 30d4 live
Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers
Amgen

Biotech pioneer: biologics and biosimilars.

2 stories · 30d0 live
Gilead Sciences

HIV, liver disease and oncology.

2 stories · 30d2 live
STAT+: Why Gilead can’t stop talking about its ambitions in immunology
AstraZeneca

Anglo-Swedish pharma: oncology, rare disease (Alexion).

1 stories · 30d3 live
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma
Biogen

Neuroscience: MS and Alzheimer's.

1 stories · 30d1 live
Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
Daiichi Sankyo

Antibody-drug conjugates (Enhertu).

1 stories · 30d2 live
Regulatory: FDA nods for Intrabio, Nuvation, Fempulse, Xenix and more
EMA

The European Medicines Agency.

1 stories · 30d1 live
Altruist Biologics preps for production following EMA GMP certification
GSK

British pharma: vaccines, HIV (ViiV) and specialty medicines.

1 stories · 30d1 live
GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior
Novartis

Swiss innovative-medicines company.

1 stories · 30d2 live
Growth mode: 3 biotechs that are staffing up after series B raises
Sanofi

French pharma: Dupixent, vaccines.

1 stories · 30d1 live
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore
Takeda

Japan's largest drugmaker.

1 stories · 30d0 live
Teva

The largest generics maker.

1 stories · 30d0 live
Vertex

Cystic fibrosis, pain and gene-editing therapies.

1 stories · 30d1 live
Lilly’s latest China drug deal; Immunovant’s setback in lupus
Bayer

German pharma and crop science.

0 stories · 30d1 live
Regulatory: FDA nods for Intrabio, Nuvation, Fempulse, Xenix and more
BioNTech

mRNA and immuno-oncology.

0 stories · 30d0 live
Bristol Myers Squibb

Oncology, immunology and cardiovascular.

0 stories · 30d0 live
Moderna

mRNA vaccines and therapeutics.

0 stories · 30d0 live
Regeneron

Biotech behind Eylea and Dupixent (with Sanofi).

0 stories · 30d0 live